Clinical Trials on New-onset type1 Diabetes in Austria

Total 697 results

University of Adelaide
Royal Adelaide Hospital

Completed

Insulin Sensitivity During Hyperbaric Oxygen Compared to Hyperbaric Air (HOTAIR4)

Insulin Resistance | Diabetes Mellitus, Type II

Australia
Texas Diabetes & Endocrinology, P.A.

Completed

FIasp® vs. Novolog® in Type 1 Diabetics Using 670G Medtronic Pump

Type 1 Diabetes Mellitus

United States
Tandem Diabetes Care, Inc.
Jaeb Center for Health Research

Completed

Control-IQ Technology in Individuals With Type 2 Diabetes (2IQ)

Type 2 Diabetes Treated With Insulin

United States
Austin Health

Completed

Reandron in Diabetic Men Witn Low Testosterone Level

Type 2 Diabetes | Hypogonadism

Australia
University of Cambridge
The Hospital for Sick Children; Pfizer; Juvenile Diabetes Research Foundation; University... and other collaborators

Completed

Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT)

Type 1 Diabetes

Canada, Australia
Boehringer Ingelheim

Completed

A Study to Determine Acute (After First Dose) and Chronic (After 28 Days) Effects of Empagliflozin (BI 10773) on Pre and Postprandial Glucose Homeostasis in Patients With Impaired Glucose Tolerance and Type 2 Diabetes Mellitus and Healthy Subjects

Diabetes Mellitus, Type 2

Austria, Germany, Italy
Scimita Operations Pty Ltd.

Completed

Translating Biometric Data Into Blood Glucose Levels

Diabetes Type 2

Australia
AstraZeneca
Eli Lilly and Company

Completed

An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Italy, Korea, Republic of, Hungary, Canada, Australia
Medical University of Vienna

Completed

Correlation of Flicker Induced and Flow Mediated Vasodilatation in Patients With Endothelial Dysfunction and Healthy Volunteers.

Hypertension | Diabetes Mellitus, Type 1 | Hypercholesterolemia | Regional Blood Flow

Austria
Bristol-Myers Squibb

Completed

Safety Study of BMS-903452 in Healthy Subjects (Panel 1-7) & Relative Bioavailability of the Crystalline and Amorphous Forms of BMS-903452 [Panels 4, 6, 11 & 12(Part A)], and Subjects With Type 2 Diabetes Mellitus (Part B)

Diabetes

United States
Cantonal Hospital of St. Gallen
Medical University of Graz; European Foundation for the Study of Diabetes

Completed

Restoration of Beta Cell Function and Cardiovascular Parameters in Relation to Adipoinsular and Enteroinsular Axes After Gastric Bypass Surgery

Diabetes Mellitus, Type 2 | Bariatric Surgery Candidate

Austria, Switzerland
National Institute of Diabetes and Digestive and...
Juvenile Diabetes Research Foundation

Terminated

Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus (TN-22)

Type1 Diabetes Mellitus

United States, Australia, Italy, United Kingdom, Sweden, Canada
Sciwind Biosciences APAC CO Pty. Ltd.
Hangzhou Sciwind Biosciences Co., Ltd.; Sciwind Biosciences USA Co., Ltd.

Recruiting

XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults

Obesity | Type 2 Diabetes Mellitus

Australia
AstraZeneca

Completed

Bioequivalence Study of Fixed Dose Combination of 2.5 mg Saxagliptin/850 mg Metformin Tablet Relative to 2.5 mg Onglyza and 850 mg Glucophage Tablets Co-Administered

Type 2 Diabetes Mellitus

United States
Novo Nordisk A/S

Completed

A Study of the Effectiveness of Xultophy® (Insulin Degludec/Liraglutide) in an Adult Real-world Population With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2 | Diabetes

Austria, Germany, United Kingdom, Sweden, Switzerland
The George Institute
Monash University; University of Sydney; The University of New South Wales

Recruiting

SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes (START)

Type 2 Diabetes

Australia
Bayer

Completed

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN)

Diabetic Nephropathies

Hong Kong, Australia, Spain, Portugal, United States, France, Canada, Netherlands, Austria, Finland, Poland, Taiwan, Hungary, Israel, Italy, South Africa, Sweden, Bulgaria, Germany, Denmark, Czechia, Korea, Republic of, Norway
AstraZeneca
Bristol-Myers Squibb

Completed

Study to Evaluate the Potential Pharmacokinetic Interaction and Pharmacodynamic Effects on Renal Parameters of Bumetanide (1mg) and Dapagliflozin (10 mg) When Co-administered in Healthy Subjects

Type 2 Diabetes Mellitus

United States
AstraZeneca
Bristol-Myers Squibb

Completed

Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects

Type 2 Diabetes Mellitus

United States
AstraZeneca
Bristol-Myers Squibb

Terminated

Effect of Rifampin on the Pharmacokinetics of Dapagliflozin in Healthy Subjects

Type 2 Diabetes Mellitus

United States
AstraZeneca

Completed

Bioequivalence Study of 500 mg and 1000 mg Glucophage (Metformin) Tablets in Healthy Subjects

Type 2 Diabetes Mellitus

United States
AstraZeneca

Completed

Pharmacokinetics and Pharmacodynamics Study of Saxagliptin in Healthy Subjects

Type 2 Diabetes Mellitus

United States
GlaxoSmithKline

Completed

A Drug Interaction Study Between Simvastatin and GSK376501

Type 2 Diabetes Mellitus

United States
AstraZeneca

Completed

Bioequivalence Study of 2.5-mg Saxagliptin and 500-mg Glucophage in Tablets and a Fixed-dose Combination Tablet in Healthy Participants

Type 2 Diabetes Mellitus

United States
MetaCure (USA), Inc.

Completed

The TANTALUS® II for the Treatment of Type 2 Diabetes (Crossover)

Diabetes Mellitus, Type 2

Austria, Germany, Italy, Poland
Hunter and New England Health

Completed

Dealing With Anxiety: A Cognitive Behavioural Program for Diabetes

Diabetes Mellitus Type 2

Australia
Hoffmann-La Roche

Completed

A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy (CANBERRA)

Diabetic Retinopathy

United States, United Kingdom, Spain, Poland, Slovakia, Australia, Puerto Rico
Insulet Corporation
Jaeb Center for Health Research

Completed

OP5-005 Using Omnipod 5 in Adults With Type 2 (SECURE-T2D)

Type2 Diabetes

United States
Xeris Pharmaceuticals
Empiristat, Inc.

Completed

G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes

Type 1 Diabetes Mellitus | Severe Hypoglycemia | Insulin Hypoglycemia

United States, Canada, Austria
Bristol-Myers Squibb

Completed

Safety Study of BMS-770767 in Subjects With Type 2 Diabetes

Diabetes Type 2

United States, Canada, Korea, Republic of, Australia
Eli Lilly and Company

Completed

A Study for Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

Brazil, Canada, Mexico, India, Australia, China, Korea, Republic of
Northern Sydney and Central Coast Area Health Service

Enrolling by invitation

Transition of Care in Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus | Transition

Australia
Menzies School of Health Research

Withdrawn

Medication in Early Diabetes (MED) Study

Diabetes Mellitus, Type 2

Australia
Eli Lilly and Company

Active, not recruiting

A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both (SURPASS-PEDS)

Glucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Type2 Diabetes | Metabolic Disease | T2DM (Type 2 Diabetes Mellitus) | T2D

United States, India, Australia, United Kingdom, Mexico, Brazil, Israel, France, Italy
Eli Lilly and Company

Completed

Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes

Diabetic Neuropathies | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Insulin-Dependent

United States, Spain, Hungary, Australia, Belgium, Denmark, Estonia, Germany, Israel
Medtronic Diabetes

Completed

User Evaluation of the MiniMed 620G and 640G Insulin Pumps

Type 1 Diabetes | Type 2 Diabetes

United Kingdom, Denmark, Australia, Spain
University of Sydney

Completed

The Effect of a Nutritional Supplement in Individuals With Type 2 Diabetes Mellitus: a Pilot Study

Diabetes Mellitus, Type 2 | Insulin Resistance

Australia
Novo Nordisk A/S

Completed

Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function

Diabetes Mellitus, Type 2 | Diabetes

Australia
Eli Lilly and Company

Completed

A Study of an Insulin Management System in Participants With Type 1 or Type 2 Diabetes

Type 1 Diabetes | Type 2 Diabetes

United States
Seton Healthcare Family
Cancer Prevention Research Institute of Texas

Completed

Sequencing T-cells in Type I Diabetes Mellitus

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

United States
Abbott Diabetes Care

Completed

An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Diabetes (IMPACT) (IMPACT)

Type 1 Diabetes Mellitus

Austria, Netherlands, Germany, Spain, Sweden
Eli Lilly and Company

Completed

A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy (PRONTO-Pump-2)

Type 1 Diabetes Mellitus

Spain, United States, France, Israel, Australia, Germany, Italy, Puerto Rico, Austria, Hungary, Canada
Zafgen, Inc.

Terminated

An Efficacy and Safety Study of Beloranib in Obese Subjects With Type 2 Diabetes Mellitus

Obesity | Type 2 Diabetes

Australia
Garvan Institute of Medical Research

Completed

Alkaline Diet for Insulin Sensitivity (ADIS)

Type 2 Diabetes Mellitus | Dysglycemia

Australia
AstraZeneca
Eli Lilly and Company

Completed

Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy

Type 2 Diabetes Mellitus

Italy, Poland, Hungary, Mexico, Greece, Australia
University of Adelaide

Recruiting

Effects of an Evening PROtein PrEload on Metabolic Health in Night ShIfT Workers (PROPENSITy) (PROPENSITy)

Type 2 Diabetes | Shift-work Disorder

Australia
University of Texas at Austin

Completed

Cognitive Training for Diabetes Self-Management

Diabetes Mellitus, Type 2

United States
GT Metabolic Solutions, Inc.

Recruiting

MagDI Australia Study

Obesity | Type 2 Diabetes

Australia
Unilever R&D
Commonwealth Scientific and Industrial Research Organisation, Australia

Completed

The Effect of Plant Sterols on the Blood Lipid Profile of Subjects With and at High Risk of Type 2 Diabetes Mellitus

Vascular Diseases | Diabetes Mellitus | Hypercholesterolemia

Australia
Sanofi

Completed

REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic Agents (REASSURE)

Diabetes Mellitus, Type 2

Australia

Clinical Trials on New-onset type1 Diabetes in Austria

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations